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Background: Transcranial Doppler (TCD) with agitated saline has been shown to
be  an  alternative  for  thedetectionofright-to-
leftshunts(RLS)withsimilardiagnosticaccuraciesastransesophagealechocar-
diography(TEE).Itishypothesizedthattheadditionofbloodtoagitatedsalineincreasesthesensiti
vity  ofTCDforthedetectionofRLS.Theaimofthismeta-
analysiswastodeterminewhetheragitatedsaline with blood increases the sensitivity of TCD
for the detection of RLS compared to agitated salinealone and other contrast agents. Method:
A systematic review of Medline, Cochrane, and Embase was per- formed to look for all
prospective studies assessing intracardiac RLS using TCD compared with TEE as the reference;
both tests were performed with a contrast agent and a maneuver to provoke RLS inall
studies.Results:Atotalof27studies(29comparisons)with1,968patientsmettheinclusioncriteria.O
f 29 comparisons, 10 (35%) used echovist contrast during TCD, 4 (14%) used a gelatin-based
solution, 12 (41%) used agitated saline, and 3 (10%) utilized 2 different contrast agents. The
addition  of  blood
toagitatedsalineimprovedthesensitivityofTCDto100%comparedtoagitatedsalinealone(96
%sen- sitivity, P=0.161), echovist (94% sensitivity, P=0.044), and gelatin-based
solutions  (93%  sensitivity,
P=0.041).Conclusion:TheadditionofbloodtoagitatedsalineimprovesthesensitivityofTC
Dforthe detection of RLS to 100% when compared to other conventional contrast
agents; theseﬁndings sup- port the addition of blood to agitated saline during TCD
bubble studies. (Echocardiography 2016;00:1–9)
Keywords:right-to-
leftshunt,patentforamenovale,transcranialDoppler,transesophageal echocardiogram
Patent  foramen  ovale  (PFO)  is  a
congenital heart defect that is  a  result
of   incomplete   fusion  of  the  septum
primum  andseptumsecundum.1Through
transient  right-to-left  shunting  (RLS),  a
PFO   may   serve   as   aconduitfor
paradoxical embolic strokes or transient
ischemic  attacks.2Although  the
CLOSURE,3RESPECT,4and PC5trials  failed
to  meet  their  primary  endpoints  by
intention-to-treatanalysis,
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2recent  meta-analyses  of
these  trials  and  obser-
vational studies suggest that
PFO  occluding  devices  may
reduce  the  recurrence   of
stroke   and  transient
ischemic  attack
comparedtomedical
treatment  in  patients  with
cryptogenic  stroke.6,7While
contrast  transesophageal
echocardiogram  (TEE)  is
considered  by  manyasthe
gold standard  for  diagnosing
PFO,8con-  trast  transcranial
Doppler (TCD) is an  alterna-
tive for the detection of RLS
with  similar  diagnostic
accuracies asTEE.9
It is hypothesized that TCD
using  agitated  saline  with
blood  produces  a  higher
sensitivity  for  the detection
of RLS compared to agitated
saline  alone.10Utility  of
agitated salinewith
TCD for Detecting Right-to-Left
Shunt
Figure 1.Selection of studies.
blood  has  also  been  observed  to
increasethesensitivity of TTE  harmonic
imagingcomparedto  agitated  saline
alone  for  the  detectionofRLS.11The
Consensus  Conference  of   Venice has
outlined  certain  key  guidelines  for
perform-  ing  a  TCD  bubble  study
including  use  ofan18-gauge  needle  in
the   cubital   vein,   preferen-  tial  utilization  of
agitated saline as thecontrast
Mojadidi, et 
al.gent, and application of the
Valsalvamaneu-ver  as  the
provocation  maneuver  for
greater   than  ten
seconds.12While  these
guidelines are based on data
derived  from  older
observational  studies,
institutional  variations  in
methodology  continue   to
exist.   The   Consensus
Conference  of  Venice  and
newer   practice
guidelinesforTCD13havenotde
lineatedadifference
between use of agitated saline with or
without blood.
In a recent meta-analysis, a review of
27stud-ies was conducted to determine
the accuracyofTCD for the detection of
RLS.  Thisanalysisdemonstrated  that
there was no signiﬁcant differ- ence in
sensitivity  or  speciﬁcity  when  different
contrast  agents  (agitated  saline,
echovistandgelatin-based  solutions)
were  utilized.9Theaimof  the  current
review was to expand on ourpriormeta-
analysis  of  TCD  to  determine
whetheragi-tated  saline  with  blood
produces  a  higher  sensi-  tivity
compared  to  agitated  saline
aloneandother contrastagents.
Methods:
A  comprehensive  systemic  search  of
Medline,  Cochrane,  and  Embase  was
conducted by the authors to look for all
the  prospective  studies  assessing  for
intracardiac RLS using TCD bubble study
with  subsequent  conﬁrmation  by  TEE
bub-  ble  study  as  the  reference
standard. The search was completed in
August  2013.  Identiﬁed  studies  were
analyzed  by  3  independent  reviewers
for  preset  inclusion  criteria  which
encompassed  (1)  original  prospective
studies, (2) subjects’age greater than 18
years, (3) studies with at least 20
subjects,  (4)  utilization  of  a  contrast
agentandprovocation  maneuver  to
calculate  TCD  andTEEaccuracies,  and
(5)  availability  of  completedatato
calculate  diagnostic  accuracies  (Fig.
1).Forstudies  that  compared  different
TCD  protocols  (such  as  comparing
accuracy  of  different  typesofcontrast)
and  also  provided  the  variables  tocal-
culate the different accuracies (i.e. true
positive,  false  positive,  false  negative,
and  true  negative),  then  each
methodology was considered asepa-rate
comparison  in  theﬁnal  analysis.  A
sensitivity analysis was then performed
to  demonstrate  the  effect  of  varying
methodologies  on  accuracyofTCD.  The
methods  of  the  study  are
describedinmore detailelsewhere.9
Statistical Analysis:
Meta-analysis  of  diagnostic  accuracy
variables   was  performed  using  Meta-
DiSc software(ver-sion 1.4).14Cochran Q
statistic  and  inconsistency  index  (I2)
were  calculated  to  assess  between-
study heterogeneity and between-study
inconsis-  tency   with   statistical
signiﬁcance   deﬁned   by  P<0.10. Due
to  anticipated  inter-study  hetero-
geneity,  a  random  effects
analysismodel(DerSimonian–Laird
estimator)15was  utilized
becauseitprovidesmoreconservativ
eest imates
TABLE I
Sensitivity Analysis of TCD Stratifying for Agitated Saline with
and without Blood
Parameter
1: Saline-blood 
versus 
salineonly
No. 
of 
Studi
es
No. 
ofPati
ents
Sensitivi
ty(95% 
CI)
Speciﬁcity
(95%CI) *LR+(95%CI) *LR-(95%CI)
Saline-blood 3 139 1(0.90,1.00) 0.83(0.74,0.89) 6.55(1.70,25.29) 0.05 (0.01,0.24)
Saline only 9 73
1
0.96 (0.93,
0.98)
0.84 (0.80, 
0.88)
5.798 (3.00, 
11.19)
0.049 (0.02, 
0.12)
P-value 0.16 0.82 0.91 0.99
2: Saline-blood
versus
echovist
Saline-blood 3 13
9
1 (0.90, 1.00) 0.83 (0.74, 
0.89)
6.55 (1.70, 
25.29)
0.05 (0.01, 
0.24)
echovist 10 61
6
0.94 (0.90,
0.96)
0.87 (0.83, 
0.90)
9.98 (4.00, 
24.92)
0.114 (0.07, 
0.18)
P-value 0.04 0.34 0.67 0.32
3: Saline-blood
versus 
gelatin
Saline-blood 3 13
9
1 (0.90, 1.00) 0.83 (0.74, 
0.89)
6.55 (1.70, 
25.29)
0.05 (0.01, 
0.24)
gelatin 4 26
6
0.93 (0.87,
0.96)
0.93 (0.87, 
0.97)
10.190 (4.57, 
22.72)
0.103 (0.054, 
0.20)
P-value 0.04 0.03 0.63 0.44
4: Saline only 
versus 
echovist
Saline only 9 73
1
0.96 (0.93,
0.98)
0.84 (0.80, 
0.88)
5.80 (3.01, 
11.19)
0.05 (0.02, 
0.12)
echovist 10 61
6
0.94 (0.90,
0.96)
0.87 (0.83, 
0.90)
9.98 (4.00, 
24.92)
0.11 (0.07, 
0.18)
P-value 0.32 0.27 0.47 0.08
5: Saline 
only 
versus 
gelatin
Saline only 9 73
1
0.96 (0.93,
0.98)
0.84 (0.80, 
0.88)
5.80 (3.01, 
11.19)
0.05 (0.02, 
0.12)
gelatin 4 26
6
0.93 (0.87,
0.96)
0.93 (0.87, 
0.97)
10.19 (4.57, 
22.72)
0.10 (0.05, 
0.20)
P-value 0.25 0.01 0.39 0.23
*LR = positive likelihood ratio; LR = negative likelihood ratio; CI = conﬁdence interval.
Figure 2. A,B. Sensitivity and speciﬁcity forest plots for studies that utilized agitated saline with blood.
of  the  pooled  data.  Subgroups  were
constructed only when≥3 studies could
be  included.  Hetero-  geneity  of
diagnostic accuracy betweensub-groups
was  assessed  by  Cochran’s  Q
testandinconsistency  index  (I2)  with  a
random  effect
model.15The“Metan”package  in  Stata,
version  12  (StataCorp  LP,  College
Station,  TX,  USA)wasused  in  the
subgroup  analysis.  Values
of95%conﬁdence  intervals  (CI)  were
used for all pooled data, all P-values are
two  tailed,  and  an  adjusted  P-value
of<0.05 was considered statisticallysig-
niﬁcant unless otherwisespeciﬁed.
Results:
Of174,961articlesidentiﬁed,27studiesme
ttheinclusion  criteria.16–42Two  studies
compared  2  different  TCD  protocols;
theﬁnal  meta-analysis
thereforeconsistedof29comparisons.Ofth
e29comparisons,  10  (35%)  used
echovist  contrast  during  TCD,20,21,24–
26,29–334  (14%)  used  a  gela-  tin-based
solution,18,20,27,4012  (41%)  useda g i -
tated   saline,16,18,23,32,34,37,38,40–42and   3(10%)
utilized  2  different  contrast
agents.22,27,28A fur- ther review of the 12
studies  that  used  agitated  saline
revealed that 3 of 12 utilized agitatedsal-ine with
blood16,38,41and 9 of 12 utilized  agi-  tated saline
without  blood.  Figure  1   describes   the  study
selection  method  with  breakdownofthe  included
studies by contrastused.
--
A  total  of  731  patients
(mean  age  50;53%male)
received  agitated  saline
alone,  139  patients  (mean
age 46; 50% male)  received
agitatedsal-ine  with  blood,
616  patients  (mean  age
46;59%male)  received
echovist,  and  266
patients(meanage 50.5;  55%
male)  received  gelatin-
basedsolu-tions.  Before
stratifying for agitated saline
con-  trast  with  and  without
blood, there wasnosigniﬁcant
difference  in  diagnostic
accuracies  when  agitated
saline, echovist,  and gelatin-
based  solutions
werecompared.9
Table  I  describes  the
results  of  the  sensitivity
analysis  after  stratifying  for
agitated  salinewithand
without  blood.  Although  the
additionofb lood  to
ag i ta te d  s a l i ne
i nc re ase d  th e
s ens i t i v i t y  o f  T CD  f o r
the  de tec t i on  o f  RLS
c ompared  to agi-tated
saline  alone  (from  96%  to
100%),  thiswasnot
statistically  signiﬁcant
(P=0.16).  Therewasno
signiﬁcant  difference  in
speciﬁcity, positive likelihood
ratio  (LR+),  and  negative
likelihood  ratio  (LR  )
comparing  agitated  saline
withandwithout  blood
(P=NS).  Agitated
salinewithblood increased the
sensitivity  of
TCDwhencompared   to
echovist    (from    94%
to100%,P=0.04)  without
compromising
speciﬁcity,LR+,and  LR
(P=NS). Compared to gelatin-
based  solutions,  agitated
saline with blood had asupe-
rior  sensitivity  (100%  vs.
93%,  P=0.041)  butaninferior
speciﬁcity  (83%  vs.  93%),
P=0.03);
--
-
Figure 3. A,B.Sensitivity and speciﬁcity forest plots for studies that utilized saline only.
there  was  no  difference  in  LR+and
LRwhencomparing  the  two  contrast
agents (P=NS).There was no difference
in  sensitivity,speciﬁcity,LR+,  and  LR
when comparing agitated  saline alone
to  echovist  (P=NS).  Compared  to
gelatin- based solutions, agitated saline
alone  hadaninferior  speciﬁcity  (84%
versus 93%, P=0.006) for the detection
of RLS; there was, however,nodifference
in  sensitivity,  LR+,  and  LR
(P=NS).Figures  2–5  illustrate  the
sensitivity  and  speci-ﬁcity  forest  plots
for the different contrastagentsutilized.
Discussion:
Our  study  demonstrates  that  the
addition   of  blood  to  agitated  saline
contrast improves the sensitivity of TCD
to 100% compared to agitated saline alone (96%
sensitivity, P=0.16), echovist
-(94%  sensitivity,  P=0.044),
and  gelatin-based  solutions
(93%  sensitivity,
P=0.041).Thisincreased
sensitivity was not countered
by  acom-promise  in
speciﬁcity,  LR+,  or  LR when
agitated  saline  with  blood
was compared to agitatedsal-
ine  alone  and  echovist;
however,  there
wasadecreased  speciﬁcity
when compared to gelatin. To
our knowledge, this is theﬁrst
meta-analysis  that compares
the  diagnostic   accuracy
ofTCDfor the detection of RLS
using  agitated
salinewithblood  compared  to
agitated saline aloneandother
contrastagents.
Lange  et  al.
demonstrated  that  a  TCD
bubble  study  utilizing
agitated  saline
withbloodgenerates  more
positive  tests  with
highershuntgrades  and
longer  embolic  tract
durationsthanagitatedsalineal
onewhenmiddlecerebralarter-
ies  were  considered
independently.43However,
Figure 4. A,B.Sensitivity and speciﬁcity forest plots for studies that utilized echovist.
the study was limited as it did not
compare thediagnostic accuracies of the
two contrast mix-tures to a reference
standard such as TEE bubblestudy or
right heart catheterization. Prior
studieshave demonstrated that
combining the patient’sblood with the
contrast agent increases the num-ber of
microbubbles within a  given
volume,which maintain a constant size
when visualizedusing a
hemocytometer.10The increased
numberof microbubbles detected at the
level of the mid-dle cerebral arteries
with TCD may explain theincreased
sensitivity when utilizing agitated
salinewith blood. In this meta-analysis,
we observed anincreased sensitivity of
TCD to 100% using salinewith blood
which is supportive of this hypothesis.Compared to
other contrast agents, agitatedsaline has the
advantage of its low cost and easy
availability.  The  addition  of
patients’ownblood(ranging
from a  drop to  4  ml)16,38,41to
the agi- tated saline mixture
is  safe  and  inexpensive,
allowing  the  detection  of  a
larger numberofmicrobubbles
during  the  bubble
study.Giventhat  the
increased  sensitivity  of
agitated saline with blood has
been  demonstrated  in
boththisstudy  utilizing  TCD
and  in  other
studiesusingTTE,11saline  with
blood  may  be  the  superior
con-  trast  in  all
bubblestudies.
TTE is the most commonly
used  modalityfordetecting
intracardiac  RLS  due  to  its
cost-effec- tiveness and easy
availability.  Due
totheposterior location of the
atria,  TTE  images
oftheseptum often have a low
resolution.Forenhanced
imaging,  the  subcostal
(subxyphoid)  four-chamber
view  is  often
utilized.However,
Figure 5. A,B.Sensitivity and speciﬁcity forest plots for studies that utilized gelatin-based solutions.
during  a  Valsalva  maneuver,  the
inﬂatinglungsand  shifting  diaphragm
often lead to a brieflossof image, usually
when  the  agitated  salinehasalready
been introduced and bubbles arecross-
ing  the  septum.  Although  cost-
effectiveandcommonly  used  for
diagnosing  intracardiacRLS,TTE  has  a
low  sensitivity.44,45In  addition,  the  dif-
ferentiation  between  intracardiac  and
intrapul-  monary  RLS  can  be  difﬁcult
using  the   standard  TTE  technique.  A
recent  meta-analysisofprospective
studies  comparing  fundamentalTTEto
TEE  as  the  reference  demonstrated  a
sensitivity  of  46%  and  speciﬁcity  of
99%.46The  use  of  sec-  ond  harmonic
imaging   with   TTE   hasnowbecome
standard  in  most  centers.  Harmonic
imaging allows better visualization of a
PFOanddifferentiation  of  the  source  of
RLS (interatrial)  septum vs.  pulmonary
veins).  In  onerecentstudy,  TTE  with
second  harmonicimagingincreased  the
sensitivity  of  TEE  to  90.5%.11However,
even  with  enhanced  TTE
imaging,TCDbubble study has a superior
sensitivity  of  97%forthe  detection  of
intracardiac RLS9as TCD is not limited by
potential  poor  echo  windowsandpossible  loss  of
imaging during the Valsalva maneuver.
TCDi s l i m i t e d b y i t s i n a b i l i t y t o v i s u a l i z e t
h e
atrial  septal  anatomy  and  inability
tod i ff e r e n t i a t e
between  cardiac  and
pulmonary  RLS.11,44Due  to its
low cost, good safety proﬁle,
and  highsen-sitivity,  we
recommend  TCD  bubble
studyusingagitated  saline
with  blood  as  an  initial
screening test  for  suspected
RLS  followed  by
TEEbubblestudy  as  a
conﬁrmatorytest.
Limitations:
Limitations  of  this  meta-
analysis
includetheheterogeneity  of
the  included  studies
andthelack of studies utilizing
power M-modeTCD.Power  M-
mode  TCD   has  been
reported  tohavea  higher
sensitivity  than  older  single-
gatedTCDsfor  the  diagnosis
of RLS when  catheterization
was  used  as  the
reference.47In  addition,  the
higher sensitivity of agitated
saline  withbloodcompared  to
agitated  saline   alone
wasnotfound  to  be
statistically   signiﬁcant;
thismayhave  been  due  to  a
lack  of
statisticalpowerconsidering
there  were  fewer  studies
utilizing  agitated  saline  with
blood  (only  3  studiescom-
pared  to  9  studies   using
saline   alone)withfewer
patients  (139  patients
compared  to731patients
using  saline  alone).  Finally,
as  the  sensi-  tivity  of  the
other  methods  is  already
high,itwould  be  difﬁcult  to
show  a  statistical  differ-
ence,  even  though  saline
with  blood
had100%sensitivity.
Conclusion:
Utility  of  agitated  saline  with  blood
improvesthesensitivity  of  TCD to  100%
when comparedtoother contrast agents.
Considering  that  theaddi-tion  of  a
patient’s  blood  to  the  agitated  saline
mixture  is  easy  to  perform,  does  not
increase cost,  and adds minimal  to no
extra  time  totheprocedure,  ourﬁndings
support the addition of blood to agitated
saline during TCDbubblestudies.
Disclosures:
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